Setofilm is the first and only 5-HT3 antagonist available in an innovative and unique dosage form (oral dispersible film) with approved indications in Prophylaxis and Treatment of acute and delayed Chemotherapy and Radiotherapy Induced Nausea and Vomiting (CINV and RINV) and Post-Operative Nausea and Vomiting (PONV) in adults and children.
Setofilm Is a thin film that fully disintegrates without water in few seconds in saliva which can be subsequently swallowed (with no residual), that makes it a convenient oral form of ondansetron specifically recommended for patients with difficulties of swallowing or risk of aspiration (children and elderly).
Setofilm Is bioequivalent to the ODT form of ondansetron with slight mint taste particularly adapted to nauseous patients, has No excipients with adverse reaction.